Form D · Pharmaceuticals
GABA Therapeutics, Inc.
Newport Beach, CA · CIK 0001789541
Offering snapshot reported Oct 10, 2023 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 26, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 10, 2023 | Initial | $500,000 | No comparison | 3 | SEC filing |
| Oct 18, 2019 | Initial | $21,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-494201
Simple Agreements for Future Equity (SAFEs)
Source: Form D, filed Oct 10, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ryan Barrett | Director |
| Florian Brand | Director |
| Olivier Dasse | Executive |
| Richard Farrell | Director, Executive |
| H. Christian Fibiger | Director |
| Christian Fibiger | Director |
| Matthias Luz | Director |
| Ian John Massey | Director, Executive |
| David George Putman | Executive |
| Srinivas Rao | Director |
| Mario Saltarelli | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5000 Birch Street, West Tower, Suite 3000
Newport Beach, CA, 92660
Newport Beach, CA, 92660